Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives

Nowadays, a potent challenge in cancer treatment is considered the lack of efficacious strategy, which has not been able to significantly reduce mortality. Chemoimmunotherapy (CIT) as a promising approach in both for the first-line and relapsed therapy demonstrated particular benefit from two key ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagherifar, Rafieh, Kiaie, Seyed Hossein, Hatami, Zahra, Ahmadi, Armin, Sadeghnejad, Abdolvahid, Baradaran, Behzad, Jafari, Reza, Javadzadeh, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052859/
https://www.ncbi.nlm.nih.gov/pubmed/33865432
http://dx.doi.org/10.1186/s12951-021-00861-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052859/
https://www.ncbi.nlm.nih.gov/pubmed/33865432
http://dx.doi.org/10.1186/s12951-021-00861-0

Ejemplares similares